findmyKOL

Cynthia Toth, MD

Enriched profile

Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology; Vice Chair for Clinical Research, Duke Eye Center · Duke University School of Medicine (Duke Eye Center)

ORCIDNPI
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2009–2026

Cynthia Toth is Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology; Vice Chair for Clinical Research, Duke Eye Center at Duke University School of Medicine (Duke Eye Center). OpenAlex indexes 587 publications with 22,657 citations (h-index 74); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 31 Aug 2026

Cynthia Toth, M.D., is Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology at Duke University School of Medicine (Duke Eye Center). The public record shows 587 publications with 22,657 citations (h-index 74), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinopathy of Prematurity Studies. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 10 companies, 11 NIH-funded awards (2009–2026).

  • Most recent indexed publication: 2024 · Journal of biomedical optics
  • Top research focus: Retinal Diseases and Treatments
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Retinopathy of Prematurity4 trialsRetinal Diseases2 trialsMacular Degeneration (AMD)1 trialEye Manifestations1 trialOptic Nerve Diseases1 trialMental Disorders1 trialEdema1 trialMacular Edema1 trialNeurodevelopmental Disorders1 trialBrain Diseases1 trialBrain Ischemia1 trialDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialCataract1 trialDiabetic Retinopathy1 trialRetinal Detachment1 trialRetinal Perforations1 trialStrabismus1 trialEpiretinal Membrane1 trialRetinal Dystrophies1 trialCorneal Diseases1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal and Macular SurgeryRetinopathy of Prematurity StudiesRetinal Imaging and AnalysisOptical Coherence Tomography Applications

Drugs & molecules

across trials, industry payments and publications
Dextenzageneric · DexamethasoneClinical trialsIndustry payments2PublicationsBrilliant blue GClinical trialsIndustry payments1PublicationsEyleageneric · AfliberceptClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Duke UniversityClinical trials13Industry paymentsOcular Therapeutix, Inc.Clinical trialsIndustry payments2AbbVie Inc.Clinical trialsIndustry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
587publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

22,657citations

Total citations across indexed works.

74h-index

Hirsch index (OpenAlex). i10-index 250.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
11NIH grants · 2009–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    69.4%
    Vascular Endothelial Growth Factor Inhibitor69.4%
    Aflibercept67%Bevacizumab33%
    Part B, office-administered24 patients
  • Sensory organs

    22.2%
    Prostaglandin Analog7.8%
    Latanoprost100%
    Part D<11 patients
    alpha-Adrenergic Agonist7.8%
    Brimonidine Tartrate100%
    Part D<11 patients
  • Musculoskeletal

    8.3%
    Cyclooxygenase Inhibitor8.3%
    Ketorolac Tromethamine100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 31 Aug 2026

11 NIH research awards on record, funded 20092026 per NIH RePORTER. The latest:

Publications

Updated 31 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 31 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Joseph A. Izatt158Sina Farsiu102Sharon F. Freedman93

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/cynthia-toth-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Cynthia-Toth-3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/DukeEye/posts/check-out-5q-with-cynthia-toth-md-as-she-shares-why-she-loves-ophthalmology-what/10155819654632830

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Other

    retinatoday.com/articles/2018-may-june/5q-with-cynthia-a-toth-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinatoday.com
  • Spotify

    open.spotify.com/episode/04Z9eC2KuGqr7pkn0xoUEw

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Ophthalmology fellowship

    University of California, Davis School of Medicine

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pratt.duke.edu
  • Ophthalmology residency

    Geisinger Medical Center

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pratt.duke.edu
  • M.D.

    Drexel University

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pratt.duke.edu
  • Board certified

    Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Editorial & leadership roles

journal and society appointments
  • Board of Directors

    International Retinal Research Foundation (IRRF)

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →irrf.org

Awards & honors

honors on the public record
7 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Professor of Biomedical Engineering

    Duke Pratt School of Engineering

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pratt.duke.edu
  • Director

    Duke Advanced Research in Spectral Domain/Swept Source OCT Imaging (DARSI) Laboratory

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu
  • Co-founder

    Duke Reading Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.